From: Signatures of human regulatory T cells: an encounter with old friends and new players
Gene symbol | Gene name | Autoimmunity |
---|---|---|
NINJ2 | Ninjurin 2 | Â |
ACTN1 | Actinin, alpha 1 | SLE, CHA |
NELL2 | NEL-like 2 | Â |
ITGB2 | Integrin, β2 | UC, MC, COPD, T2D, AS, LAD-1, RA, ALPS, SLE |
TIAF1 | TGFB1-induced antiapoptotic factor 1 | Â |
TP53INP1 | Tumor protein p53 inducible nuclear protein 1 | Â |
TRAF1 a | TNF receptor-associated factor 1 | Â |
LGALS1 | Galectin 1 | JIA, RA, IBD |
LGALS3 a | Galectin 3 | RA, JIA |
GZMA | Granzyme A | T1D, RA, SLE, IBD |
GZMK | Granzyme K | Â |
PTTG1 | Pituitary tumor-transforming 1 | Diabetes |
TRIB1 | Tribbles homolog 1 | Â |
S100A10 | S100 calcium binding protein A10 | Â |
CEB1 | Hect domain and RLD 5 | Â |
SLAMF1 | Signaling lymphocytic activation molecule family member 1 | SLE, X-linked XLP, RA, MS |
S100A4 | S100 calcium binding protein A4 | RA |
PIM1 | Pim-1 oncogene | Â |
ID2 | Inhibitor of DNA binding 2 | Diabetes |
FHIT | Fragile hisT1Dine triad gene | Â |
RBMS1 | RNA binding motif, single stranded interacting protein 1 | Â |
IFITM1 | Interferon induced transmembrane protein 1 | Â |
IL2RA a | Interleukin 2 receptor, alpha | T1D, profound cellular immunodefiency |
TNFRSF1B a | Tumor necrosis factor receptor superfamily, member 1B | MC, UC, MS, SLE |
CCR5 | Chemokine (C-C motif) receptor 5 | MS, Grave's disease, RA |
GPR2 | Chemokine (C-C motif) receptor 10 | Autoimmune skin diseases |
IL2RB | Interleukin 2 receptor, beta | ITP, RA, osteoarthritis, hemolytic anemia |
G1P2 | Interferon, alpha-inducible protein | Â |
IL1RL2 | Interleukin 1 receptor-like 2 | Â |
IL7R | Interleukin 7 receptor | SCID, RA, SLE |
CCR7 a | Chemokine (C-C motif) receptor 7 | Diabetes, SLE, MS, RA, JIA |
TNFSF5 | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) | HIGM1, Alzheimer disease, T1D, SLE, MS, AS, ITP |
CCL5 | Chemokine (C-C motif) ligand 5 | EAT, MS, diabetes, SLE, RA |
TNFRSF10B | Tumor necrosis factor receptor superfamily, member 10b | MS, RA |
SDC4 | Syndecan 4 | Â |
CTLA4 a | Cytotoxic T-lymphocyte-associated protein 4 | T1D, Grave's disease, SLE |
TFRC | Transferrin receptor | Â |
AKAP2 | A kinase (PRKA) anchor protein 2 | Â |
DGKA | Diacylglycerol kinase, alpha | Â |
PITPNC1 | PhosphaT1Dylinositol transfer protein, cytoplasmic 1 | Â |
TRGV9 | T cell receptor gamma variable 9 | Â |
CD81 | CD81 antigen | Â |
PECAM1 | Platelet/endothelial cell adhesion molecule | ITP, diabetes, AS, RA, CIA, MS |
FOXP3 | Forkhead box P3 | IPEX, T1D |
GATA3 | GATA binding protein 3 | RA, HDR syndrome |
BHLHB2 | Basic helix-loop-helix domain containing, class B, 2 | SLE |
SATB1 | Special AT-rich sequence binding protein 1 | Â |
STAT4 | Signal transducer and activator of transcription 4 | MC, EAE, UC, diabetes, COPD, SLE, arthritis |
STAT6 | Signal transducer and activator of transcription 6 | EAE, RA, autoimmune uveitis, diabetes |
MYC | v-myc Myelocytomatosis viral oncogene homolog | Diabetes, RA, SLE |
TCF7 | Transcription factor 7 (T-cell specific, HMG-box) | T1D |
XBP1 | X-box binding protein 1 | T2D, RA |
CNOT2 | CCR4-NOT transcription complex, subunit 2 | Â |
HLA-DMA | Major histocompatibility complex, class II, DM alpha | T1D, SLE, RA |
HLA-DRB1 | Major histocompatibility complex, class II, DR beta 1 | RA, MS, sarcoidosis, Sjögren's syndrome, Grave's disease, T1D |
HLA-DRB3 | Major histocompatibility complex, class II, DR beta 3 | SLE, RA, MS, sarcoidosis, Sjögren's syndrome, Grave's disease |
GBP2 | Guanylate binding protein 2, interferon-inducible | Â |
GBP5 | Guanylate binding protein 5 | Â |
SLC40A1 (a) | Solute carrier family 40 (iron-regulated transporter), member 1 | Â |
SHMT2 (b) | Serine hydroxymethyltransferase 2 (mitochondrial) | Â |
EPSTI1 | Epithelial stromal interaction 1 | Â |
NOSIP | Nitric oxide synthase interacting protein | Â |